Standard BioTools Inc. (LAB) vs Shoulder Innovations, Inc. (SI)

Standard BioTools Inc. and Shoulder Innovations, Inc. are both Medical Devices companies. Shoulder Innovations, Inc. is the larger, with a market value of $354.1M against $291.7M — 1.2× the size. Shoulder Innovations, Inc. has negative trailing earnings, so its P/E is not meaningful; Standard BioTools Inc. trades at 3.4×. Shoulder Innovations, Inc. grew revenue faster over the last twelve months: 62.9% against 30.2%. Standard BioTools Inc. has the higher net margin (100.4% vs −58.3%) and the lower return on invested capital (−93.9% vs −54.7%). Across the 17 metrics below, Standard BioTools Inc. leads on 9 and Shoulder Innovations, Inc. on 8.

Valuation

Metric LAB SI Medical Devices median
P/E 3.36 n/m 22.18
P/S 3.42 5.87 2.70
P/B 0.54 2.83 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA 1.96 n/m 11.78
EV/Sales (2.15) 4.46 2.38
Earnings yield 29.73% (11.30%) (8.22%)
Free cash flow yield (30.83%) (13.36%) (7.80%)

Profitability

Metric LAB SI Medical Devices median
Gross margin 50.49% 77.34% 56.01%
Operating margin (112.85%) (58.53%) (15.03%)
Net margin 100.37% (58.33%) (20.40%)
Free cash flow margin (97.61%) (78.39%) (7.24%)
Return on equity 17.61% (151.89%) (15.32%)
Return on assets 14.34% (30.49%) (19.72%)
Return on invested capital (93.89%) (54.72%) (10.33%)

Growth

Metric LAB SI Medical Devices median
Revenue growth (TTM) 30.23% 62.93% 8.80%
EPS growth (last fiscal year) 61.54% 98.08% —
Revenue growth, 5-year CAGR (9.19%) — 15.23%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric LAB SI Medical Devices median
Debt to equity 0.00 0.12 0.07
Current ratio 9.10 10.71 2.50
Net debt to EBITDA 1.84 4.79 0.49

Dividend

Metric LAB SI Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 — 0.00

Size

Metric LAB SI Medical Devices median
Market cap 291.69m 354.13m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack